Rights and permissions
About this article
Cite this article
Leuprorelin injectable suspension approved in Mexico for prostate cancer. Inpharma Wkly. 1441, 18 (2004). https://doi.org/10.2165/00128413-200414410-00048
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414410-00048